Literature DB >> 25355535

Red blood cell transfusion and immune function in critically ill children: a prospective observational study.

Jennifer A Muszynski1,2, Elfaridah Frazier3, Ryan Nofziger4, Jyotsna Nateri2, Lisa Hanson-Huber2, Lisa Steele2, Kathleen Nicol5, Philip C Spinella3, Mark W Hall1,2.   

Abstract

BACKGROUND: Our previous in vitro work showed that stored red blood cells (RBCs) increasingly suppress markers of innate immune function with increased storage time. This multicenter prospective observational study tests the hypothesis that a single RBC transfusion in critically ill children is associated with immune suppression as a function of storage time. STUDY DESIGN AND METHODS: Blood samples were taken immediately before and 24 (±6) hours after a single RBC transfusion ordered as part of routine care. Innate and adaptive immune function was assessed by ex vivo whole blood stimulation with lipopolysaccharide (LPS) and phytohemagglutinin, respectively. Monocyte HLA-DR expression, regulatory T cells, plasma interleukin (IL)-6, and IL-8 levels were also measured.
RESULTS: Thirty-one transfused critically ill children and eight healthy controls were studied. Critically ill subjects had lower pretransfusion LPS-induced tumor necrosis factor-α production capacity compared to healthy controls, indicating innate immune suppression (p < 0.0002). Those who received RBCs stored for not more than 21 days demonstrated recovery of innate immune function (p = 0.02) and decreased plasma IL-6 levels (p = 0.002) over time compared to children transfused with older blood, who showed persistence of systemic inflammation and innate immune suppression. RBC storage time was not associated with changes in adaptive immune function.
CONCLUSION: In this pilot cohort of critically ill children, transfusion with older prestorage leukoreduced RBCs was associated with persistence of innate immune suppression and systemic inflammation. This was not seen with fresher RBCs. RBC transfusion had no short-term association with adaptive immune function. Further studies are warranted to confirm these findings in a larger cohort of patients.
© 2014 AABB.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25355535     DOI: 10.1111/trf.12896

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  9 in total

1.  Relationship Between Adverse Tracheal Intubation Associated Events and PICU Outcomes.

Authors:  Margaret M Parker; Gabrielle Nuthall; Calvin Brown; Katherine Biagas; Natalie Napolitano; Lee A Polikoff; Dennis Simon; Michael Miksa; Eleanor Gradidge; Jan Hau Lee; Ashwin S Krishna; David Tellez; Geoffrey L Bird; Kyle J Rehder; David A Turner; Michelle Adu-Darko; Sholeen T Nett; Ashley T Derbyshire; Keith Meyer; John Giuliano; Erin B Owen; Janice E Sullivan; Keiko Tarquinio; Pradip Kamat; Ronald C Sanders; Matthew Pinto; G Kris Bysani; Guillaume Emeriaud; Yuki Nagai; Melissa A McCarthy; Karen H Walson; Paula Vanderford; Anthony Lee; Jesse Bain; Peter Skippen; Ryan Breuer; Sarah Tallent; Vinay Nadkarni; Akira Nishisaki
Journal:  Pediatr Crit Care Med       Date:  2017-04       Impact factor: 3.624

Review 2.  Red blood cell storage lesion: causes and potential clinical consequences.

Authors:  Tatsuro Yoshida; Michel Prudent; Angelo D'alessandro
Journal:  Blood Transfus       Date:  2019-01       Impact factor: 3.443

3.  2016 proceedings of the National Heart, Lung, and Blood Institute's scientific priorities in pediatric transfusion medicine.

Authors:  Pablo Cure; Melania Bembea; Stella Chou; Allan Doctor; Anne Eder; Jeanne Hendrickson; Cassandra D Josephson; Alan E Mast; William Savage; Martha Sola-Visner; Philip Spinella; Simon Stanworth; Marie Steiner; Traci Mondoro; Shimian Zou; Catherine Levy; Myron Waclawiw; Nahed El Kassar; Simone Glynn; Naomi L C Luban
Journal:  Transfusion       Date:  2017-03-28       Impact factor: 3.157

Review 4.  Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome.

Authors:  Joseph A Carcillo; Bradley Podd; Rajesh Aneja; Scott L Weiss; Mark W Hall; Timothy T Cornell; Thomas P Shanley; Lesley A Doughty; Trung C Nguyen
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

Review 5.  Immune Modulation in Pediatric Sepsis.

Authors:  Mark W Hall
Journal:  J Pediatr Intensive Care       Date:  2019-01-02

6.  Hospital Readmissions After Pediatric Trauma.

Authors:  Aline B Maddux; Peter E DeWitt; Peter M Mourani; Tellen D Bennett
Journal:  Pediatr Crit Care Med       Date:  2018-01       Impact factor: 3.624

7.  MicroRNA Profiling of Exosomes Derived from Red Blood Cell Units: Implications in Transfusion-Related Immunomodulation.

Authors:  Haobo Huang; Jinfeng Zhu; Liping Fan; Qiuyan Lin; Danhui Fu; Biyu Wei; Shijin Wei
Journal:  Biomed Res Int       Date:  2019-06-13       Impact factor: 3.411

Review 8.  Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness.

Authors:  Jennifer A Muszynski; Philip C Spinella; Jill M Cholette; Jason P Acker; Mark W Hall; Nicole P Juffermans; Daniel P Kelly; Neil Blumberg; Kathleen Nicol; Jennifer Liedel; Allan Doctor; Kenneth E Remy; Marisa Tucci; Jacques Lacroix; Philip J Norris
Journal:  Transfusion       Date:  2016-10-02       Impact factor: 3.157

9.  Early Immune Function and Duration of Organ Dysfunction in Critically III Children with Sepsis.

Authors:  Jennifer A Muszynski; Ryan Nofziger; Melissa Moore-Clingenpeel; Kristin Greathouse; Larissa Anglim; Lisa Steele; Josey Hensley; Lisa Hanson-Huber; Jyotsna Nateri; Octavio Ramilo; Mark W Hall
Journal:  Am J Respir Crit Care Med       Date:  2018-08-01       Impact factor: 30.528

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.